Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

During the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 conference, Drs. Laura Coates and Atul Deodhar debated whether axial psoriatic arthritis (axPsA) is the same as ankylosing spondylitis (AS) with psoriasis. Dr. Coates argued that AS represents a spectrum...

Полное описание

Библиографические подробности
Главные авторы:	Coates, LC, Deodhar, A
Формат:	Journal article
Язык:	English
Опубликовано:	Journal of Rheumatology Publishing 2023

Схожие документы

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
по: Alba Erra, и др.
Опубликовано: (2022-11-01)

Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
по: Elena Conesa-Nicolás, и др.
Опубликовано: (2021-01-01)

Modern imaging techniques in the diagnosis of axial spondylitis: similarities and differences between axial psoriatic arthritis and ankylosing spondylitis
по: A. V. Sukhinina, и др.
Опубликовано: (2024-02-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
по: Lubrano E, и др.
Опубликовано: (2016-10-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
по: E. E. Gubar, и др.
Опубликовано: (2023-08-01)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
по: Coates, L, и др.
Опубликовано: (2016)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
по: A. P. Rebrov, и др.
Опубликовано: (2015-03-01)

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
по: Andrea Rubbert-Roth, и др.
Опубликовано: (2023-11-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
по: M. Rossini, и др.
Опубликовано: (2015-03-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
по: T. V. Dubinina, и др.
Опубликовано: (2023-02-01)

Identification of psoriatic arthritis in patients with psoriasis
по: Coates, LC, и др.
Опубликовано: (2023)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
по: Vivekanantham, A, и др.
Опубликовано: (2024)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
по: Chia-Jung Tsai, и др.
Опубликовано: (2023-09-01)

The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
по: Ahmet Karataş, и др.
Опубликовано: (2020-10-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
по: Viola Sacchi, и др.
Опубликовано: (2010-06-01)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
по: Ashley Elliott, и др.
Опубликовано: (2019-06-01)

How should we define disease and outcomes in axial psoriatic arthritis?
по: Coates, LC
Опубликовано: (2021)

Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
по: Bolge SC, и др.
Опубликовано: (2017-03-01)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
по: Iain B McInnes, и др.
Опубликовано: (2020-02-01)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
по: Lars Erik Kristensen, и др.
Опубликовано: (2024-05-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
по: M. Elaine Husni, и др.
Опубликовано: (2022-03-01)

Ankylosing spondylitis-axial spondyloarthritis
по: Aanand Narayan Malaviya
Опубликовано: (2017-01-01)

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
по: A. Deodhar, и др.
Опубликовано: (2019-05-01)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
по: Braun, J, и др.
Опубликовано: (2023)

Methotrexate in psoriasis and psoriatic arthritis
по: Coates, L, и др.
Опубликовано: (2020)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
по: Colombo GL, и др.
Опубликовано: (2018-08-01)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
по: Alexis Ogdie, и др.
Опубликовано: (2024-09-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
по: Sumera Ghani, и др.
Опубликовано: (2023-06-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
по: Nikolay N. Murashkin, и др.
Опубликовано: (2020-12-01)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
по: Peter Nash, и др.
Опубликовано: (2023-10-01)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
по: Gia Deyab, и др.
Опубликовано: (2017-01-01)

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
по: Peter Nash, и др.
Опубликовано: (2023-02-01)

Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset
по: Sarah B. Lieber, и др.
Опубликовано: (2022-04-01)

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study
по: Joachim Sieper, и др.
Опубликовано: (2019-06-01)

Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
по: Fatma Mohammed Aboud, и др.
Опубликовано: (2023-03-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
по: Gerd R. Burmester, и др.
Опубликовано: (2024-04-01)

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis
по: C. Brock, и др.
Опубликовано: (2021-01-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
по: Krzysztof Bonek, и др.
Опубликовано: (2022-04-01)

Complications of primary total hip arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and primary osteoarthritis
по: Qiang Lian, и др.
Опубликовано: (2022-10-01)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
по: Ehab F. Girbash, и др.
Опубликовано: (2023-01-01)